Authors:
Hetherington, S
McGuirk, S
Powell, G
Cutrell, A
Naderer, O
Spreen, B
Lafon, S
Pearce, G
Steel, H
Citation: S. Hetherington et al., Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir, CLIN THER, 23(10), 2001, pp. 1603-1614
Authors:
Staszewski, S
Keiser, P
Montaner, J
Raffi, F
Gathe, J
Brotas, V
Hicks, C
Hammer, SM
Cooper, D
Johnson, M
Tortell, S
Cutrell, A
Thorborn, D
Isaacs, R
Hetherington, S
Steel, H
Spreen, W
Citation: S. Staszewski et al., Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults - A randomized equivalence trial, J AM MED A, 285(9), 2001, pp. 1155-1163
Authors:
Saez-Llorens, X
Nelson, RP
Emmanuel, P
Wiznia, A
Mitchell, C
Church, JA
Sleasman, J
Van Dyke, R
Richardson, CG
Cutrell, A
Spreen, W
Hetherington, S
Citation: X. Saez-llorens et al., A randomized, double-blind study of triple nucleoside therapy of abacavir,lamivudine, and zidovudine versus lamivudine and zidovudine in previously treated human immunodeficiency virus type 1-infected children, PEDIATRICS, 107(1), 2001, pp. NIL_25-NIL_35
Citation: S. Hetherington, Rethinking intuition: The psychology of intuition and its role in philosophical inquiry, AUST J PHIL, 78(1), 2000, pp. 142-145
Authors:
Kumar, PN
Sweet, DE
McDowell, JA
Symonds, W
Lou, Y
Hetherington, S
LaFon, S
Citation: Pn. Kumar et al., Safety and pharmacokinetics of abacavir (1592U89) following oral administration of escalating single doses in human immunodeficiency virus type 1-infected adults, ANTIM AG CH, 43(3), 1999, pp. 603-608
Authors:
Hughes, W
McDowell, JA
Shenep, J
Flynn, P
Kline, MW
Yogev, R
Symonds, W
Lou, Y
Hetherington, S
Citation: W. Hughes et al., Safety and single-dose pharmacokinetics of abacavir (1592U89) in human immunodeficiency virus type 1-infected children, ANTIM AG CH, 43(3), 1999, pp. 609-615
Authors:
Kline, MW
Blanchard, S
Fletcher, CV
Shenep, JL
McKinney, RE
Brundage, RC
Culnane, M
Van Dyke, RB
Dankner, WM
Kovacs, A
McDowell, JA
Hetherington, S
Citation: Mw. Kline et al., A phase I study of abacavir (1592U89) alone and in combination with other antiretroviral agents in infants and children with human immunodeficiency virus infection, PEDIATRICS, 103(4), 1999, pp. E471-E475